Home › NDC Lookup › RxCUI directory › RxCUI 2725597

1.7 ML denosumab-qbde 70 MG/ML Injection [Xtrenbo] — RxCUI 2725597

RxNorm drug concept · Semantic branded drug
RxCUI 2725597 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2725597
Official name1.7 ML denosumab-qbde 70 MG/ML Injection [Xtrenbo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1.7 ML Xtrenbo 70 MG/ML Injection; Xtrenbo 120 MG in 1.7 ML Injection; Xtrenbo 120 MG per 1.7 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Denosumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats osteoporosis in people at high risk for fracture, including postmenopausal women, men, and people on long-term steroids. It also helps build bone in men on prostate cance...
  • Usually once every 6 months, given under the skin by a healthcare provider. If you miss one, get it as soon as you can and your 6-month schedule restarts from then. Take your calci...
  • Back pain, limb pain, and muscle or joint aches are most common. Some people notice bladder infections, cold symptoms, or headaches. Call your doctor for muscle cramps or tingling,...
  • No dose change is needed, but advanced kidney disease or dialysis raises the risk of severe low calcium, which can be life-threatening. Your doctor should check your calcium and mi...
📖 Read our full Denosumab Injection guide →

🕸️ Concept Web — How 1.7 ML denosumab-qbde 70 MG/ML Injection [Xtrenb... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1.7 ML denosumab-qbde 70 MG/ML Injection [Xtrenbo] RxCUI 2725597

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Denosumab 993449
    • Denosumab-qbde 2725562
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xtrenbo 2725592
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Denosumab Injection 1655915
    • Denosumab-qbde Injection 2725589
    • Denosumab Injectable Product 1157742
    • Denosumab-qbde Injectable Product 2725564
    • Denosumab Injection [Xtrenbo] 2725595
    • Denosumab-qbde Injection [Xtrenbo] 2725596
    • Xtrenbo Injectable Product 2725594
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1.7 ML denosumab-qbde 70 MG/ML Injection SCD · 2725590
  • Denosumab-qbde 70 MG/ML SCDC · 2725588
  • Denosumab Injection SCDF · 1655915
  • Denosumab-qbde Injection SCDFP · 2725589
  • Denosumab Injectable Product SCDG · 1157742
  • Denosumab-qbde Injectable Product SCDGP · 2725564

Brand-Name Concepts

  • Denosumab-qbde 70 MG/ML [Xtrenbo] SBDC · 2725593
  • Denosumab Injection [Xtrenbo] SBDF · 2725595
  • Denosumab-qbde Injection [Xtrenbo] SBDFP · 2725596
  • Xtrenbo Injectable Product SBDG · 2725594
  • Xtrenbo BN · 2725592

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2725597 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9166-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9166-01) / 1.7 mL in... XTRENBO Hikma Pharmaceuticals USA Inc. 2026-01-08
Observed labelers: Hikma Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.